Interview 13 Oct 2021
Thinking About Risk Early on Is Key for Cell Therapy Success
For cell therapy to become mainstream, important issues such as management of risk and quality control need to be addressed, argues Duncan Borthwick, Global Marketing Manager at cell therapy manufacturing firm Solentim. Research and development of cell therapies, along with other advanced medicines like gene therapies, has increased exponentially over the last few years. According […]